Abbott Laboratories
Prices may be delayed up to 15 min. Not investment advice. News volume: articles about it in the 4Search index. Click a dot on the chart for the event and the news of that day.
Key statistics
Against its peers
Compare in full ›| ABT.VI | ABBOTINDIA.NS | BMY | INDSWFTLAB.BO | LLY | MOREPENLAB.NS | |
|---|---|---|---|---|---|---|
| Market cap | 164.50B | 563.64B | 120.19B | 28.01B | 1.20T | 49.40B |
| P/E (TTM) | 41.1 | 34.1 | 13.0 | 32.9 | 43.7 | 26.3 |
| Forward P/E | — | 29.1 | 8.8 | — | 26.5 | — |
| Price/book | 3.6 | 13.2 | 5.1 | 1.9 | 29.8 | 3.6 |
| Dividend yield | 2.41% | 2.04% | 4.29% | — | 0.51% | 0.22% |
| 1-year change | −13.94% | −13.88% | +23.12% | +233.57% | +25.88% | +106.25% |
| Today | −0.50% | +3.23% | +0.79% | −4.01% | −0.30% | −0.68% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All ABT.VI news ›Abbott Laboratories (NYSE: ABT), AbbVie (NYSE: ABBV), And Coca-Cola (NYSE: KO) Stand Out As Elite Dividend Compounders Built To Last
Abbott Laboratories (NYSE: ABT) made headlines this year after closing a $21 billion cash deal to acquire Exact Sciences, a company focused on cancer diagnostics. The acquisition targets one of Abbott’s slower-growing business units and…
Abbott starts trial of Encantor transcatheter aortic valve
The balloon-expandable system could complement Abbott’s existing self-expanding Navitor device. Dive Brief: Abbott said Thursday it has started the VOYAGER CE clinical trial of its investigational Encantor transcatheter aortic valve…
MedTech poised to outperform in 2027, Leerink says as Abbott upgraded
Leerink Partners on Thursday upgraded Abbott Laboratories (ABT) to Outperform from Market Perform, citing significant gains for the MedTech sector over the next 12–24 months due to multiple factors. “We have growing conviction that MedTech…
Abbott Laboratories Begins Trial of Encantor System to Treat Aortic Stenosis
Abbott Laboratories said Thursday it has started a clinical trial evaluating the safety and efficacy of its investigational Encantor software-guided balloon-expandable transcatheter aortic valve... Medical Equipment, Supplies &…
Leerink Partners Upgrades Abbott Laboratories to Outperform From In Line, $124 Price Target
Abbott Laboratories has an average rating of overweight and mean price target of $119.46, according to analysts polled by FactSet. Medical Equipment, Supplies & Distribution Leerink Partners Upgrades Abbott Laboratories to Outperform From…
If You Ran Abbott, What Would You Do?
November 19th, 2026 · by Trefis Team Today’s big story: Could Anthropic Stock Fall 25%? If you ran Abbott Laboratories (ABT), you would start with how little of each sale it keeps as profit. The business is growing, with sales rising 10.0%…
Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio Strategy
The two properties strengthen the Company's presence in Illinois, where it currently owns and manages three other properties. LAS VEGAS, NEVADA / ACCESS Newswire / January 7, 2026 / Sentinel Net Lease (the "Company") announced today that…
Abbott initiates VOYAGER clinical trial for investigational Encantor™ software-guided balloon-expandable TAVI system to treat aortic stenosis
News provided by Abbott's Encantor system includes software-guided deployment technology designed to help optimize valve expansion to the patient's unique anatomy, supporting precise implantation and consistent valve performance Encantor…
abbott laboratories - ABT
ABT Close Chg Chg % Overview Profile Financials Analyst Estimates SEC Filings Insiders About abbott laboratories - ABT Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates…
What Are Abbott Stock Bears Missing?
November 12th, 2026 · by Trefis TeamABTYTD-10.6%SPYYTD+12.0%XLVYTD+23.1%Analyze ABT →For questions about this article or underlying research, email [email protected]. Abbott Laboratories (ABT) plans to separate its nutrition business into an…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com12
- theglobeandmail.com10
- seekingalpha.com6
- themarketsdaily.com6
- trefis.com4
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 72 articles, not a forecast.